Summary
Clinical management of cardiac tachyarrhythmias is fundamentally founded on precise determination of their nature and the clinical condition in which they occur, together with knowledge of the mechanisms of action and pharmacodynamics of the antiarrhythmic drugs and understanding of the related electrical therapeutic modalities. The initial objective in the therapy of supraventricular tachyarrhythmias is control of ventricular rate and then restoration of normal sinus rhythm. In general, supraventricular disorders are treated with digitalis, vagal stimulation, quinidine, procainamide, propranolol and direct current electroshock. Ventricular tachyarrhythmias are managed with lignocaine, procainamide, quinidine, propranolol, phenytoin (diphenylhydantoin), bretylium, direct current electroshock and electrical pacemaker ventricular overdrive.
Digitalis toxicity is among the most common adverse drug reactions and may cause arrhythmias and conduction disturbances in as many as 1 of 5 patients. Particularly responsible are the electrophysiological properties of digitalis in increasing the automaticity of subsidiary pacemakers, reducing the refractory period and prolonging conduction velocity in the atria and ventricles, and delaying conduction in the atrioventricular node. Digitalis can provoke every type of cardiac arrhythmia and no specific disorder of rhythm can be considered absolutely pathognomonic of digitalis toxicity.
The factors that predispose to digitalis toxicity, as well as the onset and duration of action of the agent, must be taken into account. Potassium has relatively little influence on the toxic and the contractile actions of digitalis when the cation is administered after the glycoside has been taken up by the myocardium. In contrast, alterations in serum potassium effected before treatment with digitalis may have drastic effects on the electrophysiologic and contractile actions of the glycoside; hyperkalemia reduces the binding of digitalis to the myocardium. Phenytoin, lignocaine and propranolol are effective in terminating digitalis-provoked tachyarrhythmias, usually without inducing or worsening A-V block. Atrial or ventricular pacing to achieve electrical overdrive of the ectopic focus may be used if standard measures fail. In complete heart block, potassium should not be administered; atropine and electrical pacing should be used.
In general, antiarrhythmic agents have depressant effects on cardiac contractility which are related to dose, speed of administration, and extent of myocardial disease. In addition, these agents reduce peripheral vascular resistance. However, the negative inotropic action and vasodilator effect are usually minimal or absent in the small beginning doses used to control tachyarrhythmias. The fundamental subcellular actions of antiarrhythmic agents appear to occur as a consequence of their influence on the cardiac cell membranes and, in this manner, altered transmembrane fluxes of Na+ and K+ ions underlie their electrophysiological effects and changes in Ca++ movement mediate their contractile properties.
Similar content being viewed by others
References
Allen, J.C. and Schwartz, A.: Further therapeutic implications of potassium-digitalis interaction with the transport enzyme. Na+, K+-ATPase. Circulation 44 (Suppl.2): 134 (1971).
Amsterdam, E.; Mansour, E.; Hughes, J. et al: Present status of glucagon and bretylium tosylate; in Russek and Zohman Changing Concepts in Cardiovascular Disease, p.215 (Williams and Wilkins, Baltimore 1972a).
Amsterdam, E.A.; Massumi, R.A.; Zelis, R. and Mason, D.T.: Use of bretylium tosylate in the management of cardiac arrhythmias. Heart and Lung1: 269 (1972b).
Austen, W.G. and Moron, J.M.: Cardiac and peripheral vascular effects of lidocaine and procainamide. American Journal of Cardiology 16: 701 (1965).
Ayres, S.M. and Grace, W.G.: Inappropriate ventilation and hypoxemia as causes of cardiac arrhythmias. American Journal of Medicine 46: 495–505 (1969).
Bacaner, M.B.: Treatment of ventricular fibrillation and other acute arrhythmias with bretylium tosylate. American Journal of Cardiology 21: 530 (1968).
Beeler, G.W. Jr. and Reuter, H.: Membrane calcium current in ventricular myocardial fibers. Journal of Physiology (Lond.) 207: 191 (1970).
Beller, G.A.; Smith, T.W.; Abelmann, W.H.; Haber, E. and Hood, W.B.Jr.: Digitalis intoxication: A prospective clinical study with serum level correlations. New England Journal of Medicine 284: 989 (1971).
Bigger, J.T. Jr. and Heissenbuttel, R.H.: The use of procaine amide and lidocaine in the treatment of cardiac arrhythmias. Progress in Cardiovascular Disease 11: 515 (1969).
Bjerkelund, C.J. and Orning, O.M.: The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. American Journal of Cardiology 23: 208 (1969).
Braunwald, E.; Ross, J.Jr.; Frommer, P.L.; Williams, J.F.Jr.: Sonnenblick, E.H. and Gault, J.H.: Clinical observations on paired electrical stimulation of the heart. Effects on ventricular performance and heart rate. American Journal of Medicine 37: 700 (1964).
Braunwald, E.; Sobel, B.E. and Braunwald, N.S.: Treatment of paroxysmal supraventricular tachycardia by electrical stimulation. New England Journal of Medicine 281: 885 (1969).
Caldwell, J.H. and Greenberger, N.J.: Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digotoxin intoxication. Journal of Clinical Investigation 50: 2626 (1971).
Cobb, F.G.; Blumenschein, S.D.; Sealy, W.C. et al: Successful surgical interruption of the bundle of kent in a patient with Wolff-Parkinson-White syndrome. Circulation 38: 1018 (1968).
Cohen, L.S.; Buccino, R.A. and Morrow, A.G.: Digitalis tolerance during atrial fibrillation and normal sinus rhythm. American Journal of Cardiology 20: 229 (1967).
Cohen, L.S.; Rosenthal, J.; Homer, D.; Atkins, J.; Matthews, O. and Samoff, S.: Plasma levels of lidocaine after intramuscular administration. American Journal of Cardiology 29: 520 (1972).
Cohn, K.; Pirages, S. and Harrison, D.C.: The effects of potassium on the positive inotropic action of ouabain. American Heart Journal 73: 516 (1967).
Conn, H.L. Jr.; Conn, E.H. and Huang, L.: The possible role of reduced membrane ATPase activity in digitalis toxicity in the aged. American Association of University Cardiology Proceedings 11: 1 (1972).
Conn, R.D.: Diphenylhydantoin sodium in cardiac arrhythmias. New England Journal of Medicine 272: 277 (1965).
Damato, A.N.: Diphenylhydantoin: Pharmacological and clinical use. Progress in Cardiovascular Disease 12: 1 (1969).
DeSanctis, R.W. and Kastor, J.A.: Rapid intracardiac pacing for treatment of recurrent ventricular tachyarrhythmias in the absence of heart block. American Heart Journal 76: 286 (1968).
Doherty, J.E.: Determinants of digitalis dosage. Journal of the Arkansas Medical Society 66: 121 (1969).
Elkins, R.C.; Vasko, J.S. and Morrow, A.G.: Digitalis tolerance during atrial fibrillation and normal sinus rhythm. American Journal of Cardiology 20: 229 (1967).
Epstein, S.E.; Redwood, D.R. and Smith, E.R.: Atropine and acute myocardial infarction. Circulation 45: 1273 (1972).
Ewy, G.A.; Kapadia, G.G.; Yao, L.; Lullin, M. and Marcus, F.I.: Digoxin metabolism in the elderly. Circulation 59: 449 (1969).
Ewy, G.A.; Groves, B.M.; Ball, M.F.; Nimmo, L.; Jackson, B. and Marcus, F.: Digoxin metabolism in obesity. Circulation 44: 810 (1971).
Fisch, C.; Greenspan, K.; Knoebel, S.B. and Feigenbaum, H.: Effect of digitalis on conduction of the heart. Progress in Cardiovascular Disease 6: 345 (1964).
Fisch, C.; Knoebel, S.B.; Feigenbaum, H. and Greenspan, K.: Potassium and the nomophasic action potential, electrocardiogram, conduction and arrhythmias. Progress in Cardiovascular Disease 8: 387 (1966).
Fisch, C. and Knoebel, S.B.: Recognition and therapy of digitalis toxicity. Progress in Cardiovascular Disease 13: 71 (1970).
Friedlander, D.M.: A guide to safe and effective digitalis therapy. Drugs 3: 404–413 (1972).
Frommer, P.L.; Robinson, B.F. and Braunwald, E.: Studies on digitalis-induced arrhythmias. Journal of Pharmacology and Experimental Therapeutics 151: 1 (1965).
Frye, R.L. and Braunwald, E.: Studies on digitalis. 3. The influence of triiodothyronine on digitalis requirements. Circulation 23: 376 (1961).
Gaffney, T.E.; Braunwald, E. and Cooper, T.: Analysis of the acute circulatory effects of guanethidine and bretylium. Circulation Research 10: 83 (1962).
Giannelli, S. Jr.; Ayres, S.M.; Gomprecht, R.F.; Conklin, E.F. and Kennedy, R.J.: Therapeutic surgical division of the human conduction system. Journal of the American Medical Association 199: 155 (1967).
Gibson, D. and Sowton, E.: The use of beta-adrenergic receptor blocking drugs in dysrhythmias. Progress in Cardiovascular Disease 12: 16 (1969).
Goldsmith, C.; Kapadia, G.G.; Nimmo, L.; Murphy, C.; Moron, H. and Marcus, F.I.: Correlation of digitalis intoxication with myocardial concentration of tritiated digoxin in hypokalemic and normokalemic dogs. Circulation 40 (Suppl. 3): 92 (1969).
Grossman, J.I.; Cooper, J.A. and Frieden, J.: Cardiovascular effects of infusion of lidocaine on patients with heart disease. American Journal of Cardiology 24: 191 (1969).
Heifant, R.H.; Scherlag, B.J. and Damato, A.N.: Protection from digitalis toxicity with the prophylactic use of diphenylhydantoin sodium: an arrhythmic-inotropic dissociation. Circulation 36: 119 (1967).
Heifant, R.H.; Scherlag, B.J. and Damato, A.N.: Diphenylhydantoin prevention of arrhythmias in the digitalis-sensitized dog after direct-current cardioversion. Circulation 37: 424 (1968).
Hilmi, K.I. and Regan, T.J.: Relative effectiveness of antiarrhythmic drugs in treatment of digitalis-induced ventricular tachycardia. American Heart Journal 76: 365 (1968).
Hughes, J.L.; Mansour, E.; Salel, A.F.; Zelis, R.; Mason, D.T. and Amsterdam, E.A.: Elective conversion of atrial fibrillation: Relation of energy level, digitalis, and lidocaine to post shock rhythm. American Journal of Cardiology 26: 639 (1970).
Hurst, J.W.; Paulk, E.A.; Proctor, H.D. and Schlant, R.C.: Management of patients with atrial fibrillation. American Journal of Medicine 37: 728 (1964).
Jelliffe, R.W.: Administration of digoxin. Diseases of the Chest 56: 56 (1969).
Killip, T. and Kimball, J.T.: Treatment of myocardial infarction in a coronary care unit. American Journal of Cardiology 20: 457 (1967).
Kimball, J.T. and Killip, T.: Aggressive treatment of arrhythmias in acute myocardial infarction. Progress in Cardiovascular Diseases 10: 483 (1968).
Kirchberger, M.A.; Tada, M.; Repke, D. and Katz, A.M.: Cyclic adenosine 3′, 5′-Monophosphate-dependent protein kinase stimulation of calcium uptake by canine cardiac microsomes. Journal of Molecular and Cellular Cardiology 4: 673 (1972).
Koch-Weser, J.; Klein, S.W.; Foo-Canto, L.L. et al.: Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction. New England Journal of Medicine 281: 1253 (1969).
Kouwenhoven, W.G.; Jude, J.R. and Knickerbocker, C.G.: Closed-chest cardiac massage. Journal of the American Medical Association 173: 1604 (1960).
Lee, G.; Peng, C.L.; Mason, D.T.; Amsterdam, E.A.; Massumi, R.A. and Zelis, R.: Demonstration of linear dose-response and quantitive attenuation by potassium of the inotropic action to digitalis. Chest 62: 367 (1972).
Levine, O.R. and Somlyo, A.P.: Digitalis intoxication in premature infants. Journal of Pediatrics 61: 70 (1962).
Lindenbaum, J.; Mellow, M.H.; Blackstone, M.O. and Butler, V.P.: Variation in biologic availability of digoxin from four preparations. New England Journal of Medicine 285: 1344 (1971).
Lister, J.; Cohen, L.; Bernstein, W. et al.: Treatment of supraventricular tachycardia by rapid atrial stimulation. Circulation 38: 1044 (1968).
Lown, B.; Amarasinglham, R. and Neuman, J.: New method for terminating cardiac arrhythmias. Journal of the American Medical Association 182: 548 (1962).
Lown, B.; Kleiger, R. and Williams, J.: Cardioversion and digitalis drugs: Changed threshold to electric shock in digitalized animals. Circulation Research 17: 519 (1965).
Lown, B.: Electrical reversion of cardiac arrhythmias. British Heart Journal 29: 469 (1967).
Lown, B.; Cannon, R.L.III and Rossi, M.A.: Electrical stimulation and digitalis drugs: Repetitive response in diastole. Proceedings of the Society of Experimental Biology and Medicine 126: 698 (1967).
Lown, B. and Wittenberg, S.: Cardioversion and digitalis, III. Effect of change in serum potassium concentration. American Journal of Cardiology 21: 513 (1968).
Lucchesi, B.R.; Whitsitt, L.S. and Stickney, J.L.: Antiarrhythmic effects of beta adrenergic blocking agents. Annals of the New York Academy of Sciences 139: 940 (1969).
Marcus, F.I.; Burkhalter, L.; Cuccia, C.; Pavolovich, J. and Kapadia, G.G.: Administration of tritiated digoxin with and without a loading dose. A metabolic study. Circulation 34: 865 (1966).
Markis, J.E. and Koch-Weser, J.: Characteristics and mechanism of inotropic and chronotropic actions of bretylium tosylate. Journal of Pharmacology and Experimental Therapeutics 178: 94 (1971).
Mason, D.T. and Braunwald, E.: Mechanisms of action and therapeutic uses of cardiac drugs; in Fulton Modern Trends in Pharmacology and Therapeutics, p.112 (Butterworths, London 1967).
Mason, D.T.; Spann, J.F. Jr. and Zelis, R.: New developments in the understanding of the actions of the digitalis glycosides. Progress in Cardiovascular Disease 11: 443 (1969).
Mason, D.T.; Spann, J.F.Jr.; Zelis, R. and Amsterdam, E.A.: The clinical pharmacology and therapeutic applications of the antiarrhythmic drugs. Clinical Pharmacology and Therapeutics 11(4): 460 (1970a).
Mason, D.T.; Spann, J.F. Jr.; Zelis, R. and Amsterdam, E.A.: Effects of antiarrhythmic drugs on myocardial performance in man: Assessment by the maximal velocity of contractile element shortening. American Journal of Cardiology 25: 114 (1970b).
Mason, D.T.; Spann, J.F.Jr.; Zelis, R. and Amsterdam, E.A.: Evolving concepts in the clinical pharmacology and therapeutic uses of the antiarrhythmic drugs; in Russek and Zohman Cardiovascular Therapy: The Art and Science p.122 (Williams & Wilkins, Baltimore 1971a).
Mason, D.T.; Zelis, R.; Lee, G.; Hughes, J.L.; Spann, J.F. Jr. and Amsterdam, E.A.: Current concepts and treatment of digitalis toxicity. American Journal of Cardiology 27: 546 (1971b).
Mason, D.T.; Amsterdam, E.A.; Massumi, R.A. and Zelis, R.: Recent advances in antiarrhythmic drugs: Clinical pharmacology and therapeutics; in Eliot The Acute Cardiac Emergency p.95 (Futura, Mount Kisco,NY 1972).
Mason, D.T.; Amsterdam, E.A.; Massumi, R.A.; Mansour, E.J. and Hughes, J.L. and Zelis, R.: Combined actions of antiarrhythmic drugs: Electrophysiologic and therapeutic consideration; in Dreifus and Likoff Cardiac Arrhythmias, p.531–544 (Grune & Stratton, New York 1973a).
Mason, D.T.; Zelis, R.; Amsterdam, E.A. and Massumi, R.A.: Mechanisms of digitalis arrhythmias: Electrophysiologic and myocardial subcellular considerations; in Dreifus and Likoff Cardiac Arrhythmias, p.491–503 (Grune & Stratton, New York 1973b).
Massumi, R.A.; Amsterdam, E.A.; Zelis, R. and Mason, D.T: The digitalis glycosides: Contractile and electrophysiologic actions, clinical indications, precautions, and toxicity. Seminars in Drug Treatment 2: 221 (1972a).
Massumi, R.A.; Mason, D.T.; Amsterdam, E.A.; DeMaria, A.; Miller, R.R.; Scheinman, M.M. and Zelis, R.: Ventricular fibrillation and tachycardia after intravenous atropine for treatment of bradycardias. New England Journal of Medicine 287: 336 (1972b).
Mierzwiak, D.S.; Shapiro, W.; McNalley, M.C. and Mitchell, J.H.: Cardiac effects of diphenylhydantoin (Dilantin) in man. American Journal of Cardiology 21: 20 (1968).
Miller, R.R.; Hilliard, G.; Lies, J.E.; Massumi, R.A.; Zelis, R.; Mason, D.T. and Amsterdam, E.A.: Hemodynamic effects of procainamide in patients with acute myocardial infarction and comparison with lidocaine. American Journal of Medicine (in press, 1973).
Mixter, C.G.; Moron, J.M. and Austen, W.G.: Cardiac and peripheral vascular effects of diphenylhydantoin sodium. American Journal of Cardiology 17: 332 (1966).
Nayler, W.G.: Calcium exchange in cardiac muscle: A basic mechanism of drug action. American Heart Journal 73: 379 (1967).
Nayler, W.G.; McInnes, I.; Swann, J.B.; Race, D.; Carson, V. and Lowe, T.E.: Some effects of diphenylhydantoin and propranolol on the cardiovascular system. American Heart Journal 75: 83 (1968).
Nayler, W.G.; McInnes, I.; Carson, V.; Stone, J. and Lowe, T.E.: The effect of lignocaine on myocardial function, high energy phosphate stores, and oxygen consumption: A comparison with propranolol. American Heart Journal 78: 338 (1969).
Oliver, G.C.; Parker, B.M. and Parker, C.W.: Radioimmunoassay for digoxin. Technic and clinical application. American Journal of Medicine 51: 186 (1971).
Parmley, W.W. and Braunwald, E.: Comparative myocardial depressant and antiarrhythmic properties of d-propranolol, dl-propranolol and quinidine. Journal of Pharmacology and Experimental Therapeutics 158: 11 (1967).
Pick, A.; Langendorf, R. and Katz, L.N.: Depression of cardiac pacemakers by premature impulses. American Heart Journal 41: 49 (1951).
Prindle, K.H.; Skelton, C.L.; Epstein, S.E. and Marcus, F.I.: Influence of extracellular potassium concentration on myocardial uptake and inotropic effect of tritiated digoxin. Circulation 40 (Suppl. 3): 165 (1969).
Schmidt, D.H. and Butler, V.P. Jr.: Reversal of digoxin toxicity with specific antibodies. Journal of Clinical Investigation 50: 1738 (1971).
Schnitzler, R.; Goldseyer, B.; Westura, E. and Damato, A.: Demand coronary vein pacemakers for drug resistant supraventricular tachycardia. Circulation 44 (Suppl. 2): 97 (1971).
Schumacher, R.R.; Lieberson, A.D.; Childress, R.H. and Williams, J.R. Jr.: Hemodynamic effects of lidocaine in patients with heart disease. Circulation 37: 965 (1968).
Smith, T.W. and Haber, E.: Digoxin intoxication: The relationship of clinical presentation to serum digoxin concentration. Journal of Clinical Investigation 49: 2377 (1970).
Travel, M.E. and Fisch, C.: Repetitive ventricular arrhythmias resulting from artificial internal pacemaker. Circulation 30: 493–500 (1964).
Vassaux, C. and Lown, B.: Cardioversion of supraventricular tachycardias. Circulation 39: 791 (1969).
Waxman, M.B.; Chan, H.K. and Heimbecker, R.O.: Influence of variations in sympathetic drive on digitalis tolerance. Clinical Research 19: 763 (1971).
Williams, J.F. Jr.; Klocke, F.J. and Braunwald, E.: Studies on digitalis. 13. Comparison of the effects of potassium on the inotropic and arrhythmiaproducing actions of ouabain. Journal of Clinical Investigation 45: 346 (1966).
Zeft, J.H.; Cobb, F.R.; Waxman, M.B.; Hunt, N.C. and Morris, J.J. Jr.: Right atrial stimulation in the treatment of atrial flutter. Annals of Internal Medicine 7: 447 (1969).
Zelis, R.; Mason, D.T.; Spann, J.F. Jr. and Braunwald, E.: Effects of ventricular stimulation and potassium administration on digitalis-induced arrhythmias. American Journal of Cardiology 25: 428 (1970).
Zipes, D.P.; Wallace, A.G.; Sealy, W.C. and Floyd, W.L.: Artificial atrial and ventricular pacing in the treatment of arrhythmias. Annals of Internal Medicine 70: 885 (1969).
Zoll, P.M. and Linenthal, A.J.: Termination of refractory tachycardia by external countershock. Circulation 25: 596 (1962).
Author information
Authors and Affiliations
Additional information
Second of two parts (Part I: Mechanisms of Action and Clinical Pharmacology). Supported in part by Research Program Project Grant HL-14780 from the National Institutes of Health, Bethesda, Maryland, USA.
Rights and permissions
About this article
Cite this article
Mason, D.T., DeMaria, A.N., Amsterdam, E.A. et al. Antiarrhythmic Agents II: Therapeutic Considerations. Drugs 5, 292–317 (1973). https://doi.org/10.2165/00003495-197305040-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-197305040-00003